New asthma shot aims to challenge established treatment
NCT ID NCT07302516
Summary
This study is testing if a new drug called QL2302 works as well and is as safe as an existing drug, Tezspire, for adults with severe asthma that isn't well-controlled by standard inhalers. About 636 participants will receive a monthly injection of one of the two drugs for a year, followed by 12 weeks of observation. The main goal is to see if the new drug reduces the yearly rate of serious asthma flare-ups similarly to the established treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.